Company Filing History:
Years Active: 2008
Title: Mustapha Abarghaz: Innovator in PDE2 Inhibitors
Introduction
Mustapha Abarghaz is a notable inventor based in Wittenheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific neurological conditions. His work focuses on innovative therapeutic methods that can improve patient outcomes.
Latest Patents
Abarghaz holds a patent for "Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof." This invention relates to compounds that exhibit PDE2 inhibitory activities. The patent outlines therapeutic methods for administering these compounds, especially for treating various diseases affecting the central or peripheral nervous system. Additionally, it discusses pharmaceutical compositions that include these compounds and the methods for their preparation. He has 1 patent to his name.
Career Highlights
Mustapha Abarghaz is currently associated with Via Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, contributing to the understanding and treatment of neurological disorders.
Collaborations
Abarghaz collaborates with esteemed colleagues such as Stefano Biondi and Jérôme Duranton. Their combined expertise enhances the innovative potential of their projects and contributes to the advancement of therapeutic solutions.
Conclusion
Mustapha Abarghaz is a dedicated inventor whose work in PDE2 inhibitors is paving the way for new treatments in neurology. His contributions to the field are invaluable and demonstrate the importance of innovation in healthcare.